BIOMAT Database Logo BIOMAT Database Logo

Drug metabolising enzymes. 1980

A E McLean

UI MeSH Term Description Entries
D008862 Microsomes, Liver Closed vesicles of fragmented endoplasmic reticulum created when liver cells or tissue are disrupted by homogenization. They may be smooth or rough. Liver Microsomes,Liver Microsome,Microsome, Liver
D002273 Carcinogens Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. Carcinogen,Oncogen,Oncogens,Tumor Initiator,Tumor Initiators,Tumor Promoter,Tumor Promoters,Initiator, Tumor,Initiators, Tumor,Promoter, Tumor,Promoters, Tumor
D004790 Enzyme Induction An increase in the rate of synthesis of an enzyme due to the presence of an inducer which acts to derepress the gene responsible for enzyme synthesis. Induction, Enzyme
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001711 Biotransformation The chemical alteration of an exogenous substance by or in a biological system. The alteration may inactivate the compound or it may result in the production of an active metabolite of an inactive parent compound. The alterations may be divided into METABOLIC DETOXICATION, PHASE I and METABOLIC DETOXICATION, PHASE II.

Related Publications

A E McLean
Vitamin D and drug-metabolising enzymes.
December 2012, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology,
A E McLean
Hepatic drug metabolising enzymes in undernourished men.
December 1985, Toxicology,
A E McLean
Human drug metabolising cytochrome P450 enzymes: properties and polymorphisms.
January 2004, Naunyn-Schmiedeberg's archives of pharmacology,
A E McLean
Pharmacogenetics of drug metabolising enzymes: importance for personalised medicine.
April 2003, Clinical chemistry and laboratory medicine,
A E McLean
Xenobiotic Metabolising Enzymes: Impact on Pathologic Conditions, Drug Interactions and Drug Design.
January 2019, Current topics in medicinal chemistry,
A E McLean
Proteomic characterisation of drug metabolising enzymes and drug transporters in pig liver.
October 2020, Xenobiotica; the fate of foreign compounds in biological systems,
A E McLean
Role of efflux pumps and metabolising enzymes in drug delivery.
July 2005, Expert opinion on drug delivery,
A E McLean
Selenium deficiency, the drug metabolising enzymes and mycotoxicoses in sheep.
January 1982, New Zealand veterinary journal,
A E McLean
Ophthalmic drug delivery considerations at the cellular level: drug-metabolising enzymes and transporters.
September 2005, Expert opinion on drug delivery,
A E McLean
Induction of drug metabolising enzymes: pharmacokinetic and toxicological consequences in humans.
June 2000, Clinical pharmacokinetics,
Copied contents to your clipboard!